USPTO serial 76252920
NEURO3D
Reviewed by CopyMark Law Group
Reg. 2755046Status 710
- Filing date
- Status date
- Registration date
- Aug 26, 2003
- Examiner
- ESTRADA, LINDA M
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with NEURO3D?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
68100 Mulhouse, FR
68100 Mulhouse, FR
68100 Mulhouse, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ROBERT J PATCH
MARK LEBOW YOUNG & THOMPSON209 Madison StreetSuite 500Alexandria, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Culture broth for scientific research uses in bacteriology; nutritive substances for microorganisms, namely culture media comprising amino acids, vitamins, antibiotics, growth factors, cutykines and serum all for scientific or medical research uses; compounds of small molecules, peptides and peptides mimetics, active on the nervous system of human beings and animals all for scientific or medical research uses; kits comprised of cells for the preparation of cells for medical research uses | SECTION 8 - CANCELLED | — |
| 005 | Biological preparations for use in the treatment of central and peripheral nervous system disorders for human and veterinary purposes; nutritive substances for microoganisms, namely culture media comprising amino acids, vitamins, antibiotics, growth factors, cutykines and serum for medical or clinical uses; cells for medical, pharmaceutical, veterinary or clinical use, namely for use in gene therapy and cell therapy; compounds or small molecules, peptides and peptides mimetics, active on the nervous system of human beings and animals all for medical or clinical uses; kits comprised of cells for the preparation of cells for medical purposes not medical research uses | SECTION 8 - CANCELLED | — |
| 009 | Computer programs for use in product synthesis, selection, validation and clinical development in the field of pharmaceuticals; computer programs for use in management of scientific and medical research programs; downloadable electronic publications in the nature of manuals, books, reviews, newsletters and academic papers in the fields of science and medicine | SECTION 8 - CANCELLED | — |
| 042 | Fundamental and applied research and scientific research for others in medical, biomedical, chemical, pharmaceutical, veterinary, farm produce industry or agricultural fields; licensing of intellectual property rights; developments of computer software for scientific research; conducting clinical tests for third parties, in particular in the field of treatment of nervous system pathologies; expertise in the pharmaceutical field, namely, expert witness services in the pharmaceutical field, providing opinions on pharmaceutical matters; consulting and studies in the field of pharmaceutical products synthesis, selection, validation and clinical development; providing on-line access to scientific and medical databases | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NEURO 3D
- Other trademarks owned by NEURO 3D
- Other trademarks owned by NEURO 3D
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named NEURO3D
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 3, 2010 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 15, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 6, 2007 | CFIT | CASE FILE IN TICRS | — |
| Aug 26, 2003 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 3, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 14, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 15, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 22, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 22, 2002 | PAPER RECEIVED | — | |
| Jun 24, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 7, 2002 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Feb 7, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2001 | DOCK | ASSIGNED TO EXAMINER | — |